We recently compiled a list of the 10 Worst Performing Healthcare Stocks in 2024. In this article, we are going to take a ...

Although excellent medical care is always in high demand, the healthcare sector continuously evolves. Companies aren't ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/90.BMDkfsfZ.js ...

Investment analysts at Leerink Partnrs lifted their Q4 2024 earnings per share estimates for shares of DexCom in a note ...

We recently compiled a list of the Wells Fargo’s Best Growth Stocks: 28 Stocks With The Highest Consensus EPS Growth ...

Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Mid Cap Growth Fund” third quarter ...

Leerink Partners analyst Mike Kratky maintained a Buy rating on Dexcom (DXCM – Research Report) on November 25 and set a price target of ...

We recently published a list of 12 High Growth Large Cap Stocks to Buy Now. In this article, we are going to take a look at ...

It's not always easy to be a long-term investor, particularly when contending with the natural cyclicality that the stock ...

DexCom invests $75M in Finnish health tech firm ŌURA, forming a strategic partnership to integrate glucose data with vital ...

Bank of America Securities analyst Travis Steed maintained a Buy rating on Dexcom (DXCM – Research Report) today. The company’s shares opened today at $74.85. Don't Miss our Black Friday Offers: Steed ...

Shares of DexCom, Inc. (NASDAQ:DXCM – Get Free Report) have been given a consensus rating of “Moderate Buy” by the eighteen analysts that are covering the stock, Marketbeat reports. Six equities ...